サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1777532

仙腸関節固定注射とRFアブレーションの世界市場

Sacroiliac Joint Fusion Injections and RF Ablation

出版日
ページ情報
英文 364 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
仙腸関節固定注射とRFアブレーションの世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 364 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

仙腸関節固定注射とRFアブレーションの世界市場は2030年までに15億米ドルに到達

2024年に4億9,840万米ドルと推定される仙腸関節固定注射とRFアブレーションの世界市場は、分析期間2024～2030年にCAGR 20.1％で成長し、2030年には15億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである変性仙骨腰痛症は、CAGR 22.0％を記録し、分析期間終了時には9億8,930万米ドルに達すると予測されます。仙骨破壊セグメントの成長率は、分析期間中CAGR16.7％と推定されます。

米国市場は1億3,580万米ドルと推定、中国はCAGR26.6％で成長予測

米国の仙腸関節固定注射とRFアブレーション市場は、2024年に1億3,580万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3億4,540万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは26.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ14.8%と18.3%と予測されています。欧州では、ドイツがCAGR約16.1%で成長すると予測されています。

世界の仙腸関節固定注射とRFアブレーション市場- 主要動向と促進要因のまとめ

仙腸関節固定注射とRFアブレーションとは何か、なぜ非外科的SI関節疼痛管理の鍵となるのか？

仙腸関節（SI）注射と高周波（RF）アブレーションは、慢性腰痛の重大な原因であるSI関節関連疼痛の診断と管理に使用される2つの主要な非外科的介入です。SI関節注射は、コルチコステロイドや麻酔薬を関節に直接投与することで、炎症を抑え、一時的な痛みを緩和します。また、注射後に疼痛緩和が認められた場合、SI関節の病態を確認するために診断的に使用されます。一方、RFアブレーションは高周波電流を用いて、SI関節から痛みの信号を伝達している知覚神経を加熱し、無効化するもので、注射よりも長期にわたって痛みを緩和することができます。

どちらの手技も、外科的仙腸関節固定術を検討する前の重要な治療ステップとなります。これらの手技は、精度と安全性のために、画像ガイダンス（透視またはCT）のもと、外来で行われるのが一般的です。これらの手技は、すぐには手術ができない患者、手術を遅らせたい患者、手術手技を複雑にする合併症を持つ患者にとって、特に有用です。SI関節痛が臨床的に認識されるようになり、診断精度が向上するにつれて、これらの非手術的処置は、集学的疼痛管理戦略の最前線のソリューションとして支持されるようになってきています。

技術革新はSI関節注射とRFアブレーションの効果と安全性をどのように高めているのか？

技術の進歩により、SI関節注射とRFアブレーションの両方の技術が洗練され、その精度、有効性、疼痛緩和の持続時間が向上しています。注射は現在、超音波ガイドと画像融合技術を活用することで、より正確な針の配置が可能になり、神経や血管を傷つけるリスクが減少しています。長時間作用型のコルチコステロイドや、血小板豊富血漿（PRP）や幹細胞製剤などの生物学的注射剤の使用は、抗炎症効果を持続させ、一時的な症状抑制にとどまらず関節の治癒を促進するために研究されています。

RFアブレーションでは、電極設計、アブレーションアルゴリズム、手技において大きな技術革新が起こっている。冷却RFアブレーションは、より大きな病変サイズを提供し、変化しやすい神経解剖学的構造の治療を改善する優れた方法として台頭してきており、特にSI関節の神経支配を担う仙骨外側枝に有益である。パルスRFや複数病変RFプローブも、疼痛緩和期間を延長しながら組織損傷を最小限に抑えるために研究されています。さらに、リアルタイムの神経マッピングと神経モジュレーション技術は、アブレーション手技中の神経ターゲットの特異性を高めています。

使い捨ての無菌RFキット、自動化されたアブレーション・コンソール、治療計画や治療後のフォローアップを合理化する統合型疼痛管理ソフトウェア・プラットフォームの開発により、患者の快適性と安全性はさらに向上しています。これらの技術革新により、SI関節インターベンションはより一貫性があり、再現性が高くなり、疼痛専門医とインターベンショナル脊椎医の双方にとって魅力的なものとなっています。

市場需要を牽引する患者集団と臨床使用事例は？

SI関節注射とRFアブレーションの需要は、多様な患者層、特に仙腸関節変性症、姿勢ストレス、外傷による機能障害を起こしやすい40歳以上の成人の間で増加しています。腰椎手術、特に腰椎固定術の既往がある患者は、隣接するSI関節の痛みを発症するリスクが高く、再手術を検討する前に非外科的介入に頼ることが多いです。同様に、靭帯の弛緩や生体力学的歪みによる産後の骨盤痛を経験している女性も、これらの手術を紹介されることが多くなっています。

このような介入はまた、迅速な回復を求め、手術によるダウンタイムを避けたいと考えるスポーツ選手や活動的な人々の間でも人気を集めています。手術のリスクが高い高齢者や複数の合併症を持つ患者においては、注射やRFアブレーションは貴重な長期管理手段として役立っています。さらに、肥満、変形性関節症、座りっぱなしのライフスタイルによる関節機能障害の有病率の増加により、SI関節痛の治療を受ける患者層が広がっています。

ヘルスケアシステムは、エビデンスに基づくケアパスとほとんどの新興国市場での保険適用に支えられ、SI関節注射とアブレーションを慢性疼痛管理プログラムに組み込むようになってきています。集学的な脊椎クリニックや外来手術センターは、その低侵襲性、低合併症率、費用対効果の高さから、これらの治療の拠点となりつつあります。

仙腸関節固定注射とRFアブレーションの世界市場成長の原動力は？

世界の仙腸関節固定注射とRFアブレーション市場の成長は、SI関節機能不全の有病率の上昇、臨床意識と診断精度の向上、非外科的疼痛管理に対する需要の高まりなど、いくつかの要因によって牽引されています。低侵襲のインターベンショナルペインプラクティスの拡大は、外来でリスクの少ない手技を好む患者の嗜好と相まって、市場導入を加速させています。

画像誘導インターベンション、神経焼灼システム、再生注射剤などの技術的進歩により、治療成績が向上し、使用事例が拡大しています。加えて、北米、欧州、そしてアジア太平洋地域でも償還制度の枠組みが整備されつつあり、公的、私的医療システムの両方において、より幅広い利用が促されています。腰痛の集学的治療モデルにSI関節治療が組み込まれ、価値観に基づくヘルスケアとオピオイド節約戦略へのシフトが、注射とRFアブレーションの需要をさらに押し上げています。

脊椎や痛みの専門家が仙腸関節を慢性疼痛の重要な原因として認識するようになり、標的を絞った画像誘導による介入の役割は拡大し続けています。継続的な技術革新、低侵襲ソリューションに対する患者の需要の高まり、臨床応用の拡大により、SI関節注射とRFアブレーション市場は、今後も世界的に持続的な拡大が見込まれています。

セグメント

適応症（退行性仙腸炎、仙骨破壊、外傷）;タイプ（診断、治療）;エンドユーザー（病院、外来手術センター、その他）

調査対象企業の例

  • Abbott Laboratories
  • Aesculap Implant Systems, LLC
  • Amedica Corporation
  • Aurora Spine Corporation
  • Boston Scientific Corporation
  • CornerLoc
  • Globus Medical, Inc.
  • Life Spine, Inc.
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • PainTEQ
  • RTI Surgical Holdings, Inc.
  • SI-BONE, Inc.
  • Stratus Medical
  • Surgalign Holdings, Inc.
  • Tenon Medical, Inc.
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Zyga Technology, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32860

Global Sacroiliac Joint Fusion Injections and RF Ablation Market to Reach US$1.5 Billion by 2030

The global market for Sacroiliac Joint Fusion Injections and RF Ablation estimated at US$498.4 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 20.1% over the analysis period 2024-2030. Degenerative Sacroilitis, one of the segments analyzed in the report, is expected to record a 22.0% CAGR and reach US$989.3 Million by the end of the analysis period. Growth in the Sacral Disruption segment is estimated at 16.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$135.8 Million While China is Forecast to Grow at 26.6% CAGR

The Sacroiliac Joint Fusion Injections and RF Ablation market in the U.S. is estimated at US$135.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$345.4 Million by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.8% and 18.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.1% CAGR.

Global Sacroiliac Joint Fusion Injections and RF Ablation Market - Key Trends & Drivers Summarized

What Are Sacroiliac Joint Fusion Injections and RF Ablation, and Why Are They Key to Non-Surgical SI Joint Pain Management?

Sacroiliac (SI) joint injections and radiofrequency (RF) ablation are two leading non-surgical interventions used for the diagnosis and management of SI joint-related pain, a significant contributor to chronic low back pain. SI joint injections involve the targeted delivery of corticosteroids and/or anesthetics directly into the joint to reduce inflammation and provide temporary pain relief. They are also used diagnostically to confirm SI joint pathology when pain relief is observed following the injection. In contrast, RF ablation uses high-frequency electrical currents to heat and disable the sensory nerves transmitting pain signals from the SI joint, offering longer-lasting relief than injections.

Both techniques serve as critical therapeutic steps before considering surgical sacroiliac joint fusion. They are commonly performed in outpatient settings under image guidance (fluoroscopy or CT) for precision and safety. These interventions are particularly valuable for patients who are not immediate surgical candidates, wish to delay surgery, or have comorbidities that complicate operative procedures. As SI joint pain becomes more clinically recognized and diagnostic accuracy improves, these non-surgical procedures are gaining traction as frontline solutions in multidisciplinary pain management strategies.

How Are Innovations Enhancing the Effectiveness and Safety of SI Joint Injections and RF Ablation?

Technological advancements are refining both SI joint injections and RF ablation techniques, improving their precision, efficacy, and duration of pain relief. Injections now leverage ultrasound-guided and image-fusion techniques, allowing for more accurate needle placement and reduced risk of nerve or vascular injury. The use of long-acting corticosteroids and biologic injectables-such as platelet-rich plasma (PRP) and stem cell formulations-is being explored to prolong anti-inflammatory effects and promote joint healing beyond temporary symptom suppression.

In RF ablation, significant innovation is occurring in electrode design, ablation algorithms, and procedural techniques. Cooled RF ablation is emerging as a superior method, offering larger lesion sizes and improved treatment of variable nerve anatomy, which is especially beneficial for the sacral lateral branches responsible for SI joint innervation. Pulsed RF and multi-lesion RF probes are also being investigated to minimize tissue damage while extending the duration of pain relief. Additionally, real-time nerve mapping and neuromodulation technologies are enhancing the specificity of nerve targeting during ablation procedures.

Patient comfort and safety are being further improved with the development of disposable, sterile RF kits, automated ablation consoles, and integrated pain management software platforms that streamline treatment planning and post-procedural follow-up. These innovations are making SI joint interventions more consistent, reproducible, and appealing to both pain specialists and interventional spine physicians.

Which Patient Populations and Clinical Use Cases Are Driving Market Demand?

The demand for SI joint injections and RF ablation is increasing among diverse patient demographics, particularly among adults aged 40 and above who are more prone to sacroiliac degeneration, postural stress, or trauma-induced dysfunction. Patients with a history of lumbar spine surgery-especially lumbar fusion-are at elevated risk of developing adjacent SI joint pain and often turn to non-surgical interventions before considering revision surgery. Similarly, women experiencing postpartum pelvic pain due to ligamentous laxity or biomechanical strain are increasingly being referred for these procedures.

These interventions are also gaining popularity among athletes and active individuals who seek quicker recovery and want to avoid surgical downtime. In elderly patients or those with multiple comorbidities, where surgery poses higher risks, injections and RF ablation serve as valuable long-term management tools. Moreover, the increasing prevalence of obesity, osteoarthritis, and sedentary lifestyle-induced joint dysfunction is broadening the patient base for SI joint pain treatment.

Healthcare systems are increasingly integrating SI joint injections and ablation into chronic pain management programs, supported by evidence-based care pathways and insurance coverage in most developed markets. Multidisciplinary spine clinics and ambulatory surgery centers are becoming hubs for these procedures, given their minimally invasive nature, low complication rates, and strong cost-effectiveness profile.

What Is Driving the Growth of the Global Sacroiliac Joint Fusion Injections and RF Ablation Market?

The growth in the global sacroiliac joint fusion injections and RF ablation market is driven by several factors, including rising prevalence of SI joint dysfunction, increased clinical awareness and diagnostic accuracy, and growing demand for non-surgical pain management alternatives. The expansion of minimally invasive interventional pain practices, coupled with patient preference for outpatient, low-risk procedures, is accelerating market adoption.

Technological advancements in image-guided intervention, nerve ablation systems, and regenerative injectables are enhancing treatment outcomes and broadening use cases. Additionally, supportive reimbursement frameworks in North America, Europe, and increasingly in Asia-Pacific are encouraging wider use in both public and private healthcare systems. The integration of SI joint procedures into multidisciplinary care models for low back pain, along with a shift toward value-based healthcare and opioid-sparing strategies, is further boosting the demand for injections and RF ablation.

As spine and pain specialists increasingly recognize the sacroiliac joint as a significant source of chronic pain, the role of targeted, image-guided interventions continues to grow. With ongoing innovation, rising patient demand for minimally invasive solutions, and expanding clinical application, the SI joint injections and RF ablation market is poised for sustained global expansion in the years ahead.

SCOPE OF STUDY:

The report analyzes the Sacroiliac Joint Fusion Injections and RF Ablation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Degenerative Sacroilitis, Sacral Disruption, Trauma); Type (Diagnosis, Treatment); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Aesculap Implant Systems, LLC
  • Amedica Corporation
  • Aurora Spine Corporation
  • Boston Scientific Corporation
  • CornerLoc
  • Globus Medical, Inc.
  • Life Spine, Inc.
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • PainTEQ
  • RTI Surgical Holdings, Inc.
  • SI-BONE, Inc.
  • Stratus Medical
  • Surgalign Holdings, Inc.
  • Tenon Medical, Inc.
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Zyga Technology, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sacroiliac Joint Fusion Injections and RF Ablation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Sacroiliac Joint Dysfunction Drives Demand for Sacroiliac Joint Fusion Injections and RF Ablation
    • Surge in Minimally Invasive Spine Procedures Accelerates Market Adoption of Sacroiliac Joint Fusion Injections and RF Ablation
    • Rising Patient Demand for Non-Surgical, Effective Pain Management Options Propels Growth in Sacroiliac Joint Injections and RF Ablation
    • Technological Advancements in Radiofrequency Ablation Techniques Strengthen the Business Case for RF Ablation in Sacroiliac Joint Pain Relief
    • Expansion of Outpatient Spine Care Centers Increases Market Opportunity for Sacroiliac Joint Fusion Injections and RF Ablation
    • Growing Awareness of Sacroiliac Joint Dysfunction as a Cause of Chronic Back Pain Spurs Demand for Targeted Injections and Ablation Treatments
    • Increasing Focus on Reducing Surgical Risk and Recovery Times Drives Adoption of Sacroiliac Joint Fusion Injections and RF Ablation
    • Surge in Development of Combined Injection and RF Ablation Therapies Creates New Opportunities for Integrated Pain Management Solutions
    • Rising Investment in Spine and Orthopedic Surgery Innovations Drives Growth in Sacroiliac Joint Fusion Injections and RF Ablation Technologies
    • Increasing Focus on Personalized Pain Management and Targeted Therapies Expands Market for Sacroiliac Joint Fusion Injections and RF Ablation
    • Growing Role of Regenerative Medicine and Biologics in Pain Management Expands the Reach of Sacroiliac Joint Fusion Injections
    • Surge in Medical Tourism for Spine and Orthopedic Treatments Generates Demand for Sacroiliac Joint Fusion Injections and RF Ablation Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sacroiliac Joint Fusion Injections and RF Ablation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Sacroilitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Sacroilitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Sacroilitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sacral Disruption by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sacral Disruption by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Sacroiliac Joint Fusion Injections and RF Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Degenerative Sacroilitis, Sacral Disruption and Trauma Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroilitis, Sacral Disruption and Trauma for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by Type - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Sacroiliac Joint Fusion Injections and RF Ablation by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION